Get started

Bollis

$BYOC 1 Month EMA (9) and SMA (20) Pinching Affirmed Spprt .103$BYOC 1 month chart shows the pinching of the simple moving average and the exponential moving average following trading sideways for about two weeks now after a much needed consolidation down to the 60% FIB Retracement level. RSI currently at 60 and all indicators point to a bullish uptrend following the much anticipated upcoming news of 2 or more acquisitions to come. The first acquisition took it from .02 to .16 I anticipate the 2nd should take it from .15-.20 (If that is where we are at the time of announcement) to .60 or higher. Read below in the links to see other DD I've discussed about it.
OTC:BYOCLong
by StockGuild
$ETBI Bounces Off Ultimate support following Cloud .10+ MTMain Take Aways: Here's a Recap of a Phone Call with the CEO today: 1. CEO said they are writing up the 10k as we speak to go current on OTCmarkets. She will have it in the hands of the audiotors by EOW. 2. She said the most recent 8k reflects the remaining dilution that is being used to :"reduce debt" there are no plans to do anymore at this time and she received notice from her transfer agent yesterday that the dilution had been near completion as she said TA explained " all shares have been returned". 3. I asked about updates in the direction of the company: She said they will have many updates in the next couple of weeks in regard to the future of the company and the direction they are going in, she sounded very excited. 4. She is well aware of the stock price. She knows its down today and almost by her tone seemed like she felt bad saying it has to be holders from under a penny and she even used the word "subs" because she received confirmation from them that shares had been returned. Them=transfer agent 5. She said I can call back anytime I have more concerns or questions. She is always open to talk and was not only smart, but I could feel the honesty, seriously best OTC CEO I have had a phone call with. - Sunnyland
OTC:ETBILong
by StockGuild
$ENDV Update on Upcoming Catalysts and Pennant Breakout$ENDV Upcoming Catalysts: 1. Pre-Clinical Studies To Be Completed in first quarter of 2017 2. Application for IND Orphan Drug Status for its Cytotronics Product 3. Over 20 Patent Applications OWNED by the CEO and the Company 4. 10 Form 4s filed since Dec 2016 for Insider purchases of stock 5. A "Strategic Healthcare" Institutional Investor has Ponied up $15 mil to buy back Converts 6. Company paying off the rest of its debt with $2.2 million 7. Uplistment to a "National" exchange being considered 8. Has won their injunction against Kodiak Capital and other Financiers for diluting the stock Chart: There is now a clear pennant forming on the chart, support has held tremendously and the RSI and Fibs have reset to levels corresponding with a second major move up. All marks are checked and it looks ready. Pre-Clinical trials expected in the first quarter of this year.
OTC:ENDVLong
by StockGuild
$DRYS Cloud Breakout and Positive Move Affirmation$DRYS had a good day today. We all know this stock and its shenanigans well, it seems the offering to Kalani might finally be paid completely off therefore the stock is showing tremendous strength as of lately. One thing to note is the Ichimoku Cloud break. The first time since the last break where the stock ran almost 100%. Also to note is that all levels of support held today and it's making higher lows. Overall it looks like an uptrend has been confirmed.
DLong
by StockGuild
1
$ENDV Excellent Breakout Pattern ConfirmedBreakout past the 50DMA was a key point today. PARSAR flip Bolli and Ichimoku Cloud break. This move is mostly due to immense fundamentals at work and not an actual technical push, which is the best part, if you remember $OWCP this is similar in terms of fundamentals, but with much more potential and in term a much higher ROI. One of my 3 long term holds as of today. 1. Application for Orphan Drug Status Push 2. Preclinical Studies 3. Application for Uplistment 4. Debt being bought by the company and a interested major investor 5. Insider buying through multiple Form 4s 6. Multiple Patents for their Medical Technology
OTC:ENDVLong
by StockGuild
1